NEW YORK (GenomeWeb) – German pathology products developer Leica Biosystems is teaming up with RNA biomarker analysis firm Advanced Cell Diagnostics to develop and commercialize tissue-based diagnostic tests, the companies announced today.

The new diagnostics will combine ACD's RNAscope in situ hybridization assays with Leica's BOND clinical advanced staining instruments, the firms added. The tests will be co-branded and commercialized exclusively by Leica for use in clinical laboratories.

Further terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.